Histone deacetylase inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells
Schölz, C.; Chen, L.; Zutz, A.; Keppler, O. T.; Philippou-Massier, J.; Blum, H.; Liebner, T.; Choudhary, C.
Show abstract
While current combined antiretroviral therapy (cART) allows control of HIV replication in patients and effectively suppresses plasma viral loads, it is unable to target latent reservoirs, which are responsible for virus rebound after discontinuation of therapy. Several histone deacetylase inhibitors (HDACIs) have been shown to target reservoirs and to reactivate latent HIV. While this effect is highly desired, it carries the risk that HIV-1 may be reactivated in tissue compartments were cART concentrations are insufficient and thus leading to de novo infections in this sites. To address this concern, we evaluated the effect of different HDACIs for their ability to reverse HIV latency and to modulate de novo infections. Two of the inhibitors, sodium butyrate and bufexamac, significantly inhibited de novo HIV-1 infection in activated CD4+ T-cells. Transcriptome and proteome analysis indicated global changes of protein abundancies, exhibited reduced proliferation of CD4+ T-cells, and revealed butyrate-based proteasomal degradation of EP300, an important factor for HIV-1 replication. Our results disclose new potential treatment strategies and minimizes the concern of potential reservoir reseeding by HDACIs.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580 97%
- Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways 96%
- NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner 96%
Similar papers in this journal
Similar papers in this journal
- Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis 95%
- The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load and total HIV-1 DNA in HIV-1 infected humanized mice 94%
- Identification of HIV-Reservoir Cells with Reduced Susceptibility to Antibody-Dependent Immune Response 94%
Similar papers in this journal
- Expression of Intron-containing HIV-1 RNA Induces NLRP1 Inflammasome Activation in Myeloid Cells 94%
- The Host Cell's Endoplasmic Reticulum Proteostasis Network Profoundly Shapes the Protein Sequence Space Accessible to HIV Envelope 93%
- A genome-wide genetic screen identified targets for destabilizing the parasitophorous vacuole of Chlamydia trachomatis 92%
Similar papers in this journal
- Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents 93%
- FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling 93%
- Loss of Lamin A leads to the nuclear translocation of AGO2 and compromised RNA interference 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.